These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6420191)

  • 1. Platelet aggregating activity of lysophosphatidic acids is not related to their calcium ionophore properties.
    Simon MF; Chap H; Douste-Blazy L
    FEBS Lett; 1984 Jan; 166(1):115-9. PubMed ID: 6420191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diacylglycerol causes Ca release from the platelet dense tubular system: comparisons with Ca release caused by inositol 1,4,5-triphosphate.
    Brass LF; Laposata M
    Biochem Biophys Res Commun; 1987 Jan; 142(1):7-14. PubMed ID: 3493001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid can activate platelets without increasing 32P-labelling of phosphatidic acid.
    Gerrard JM; Robinson P
    Biochim Biophys Acta; 1984 Oct; 795(3):487-92. PubMed ID: 6433985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid.
    Watson SP; McConnell RT; Lapetina EG
    Biochem J; 1985 Nov; 232(1):61-6. PubMed ID: 3853461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate: characterization of its inhibition of platelet aggregation.
    Nugent D; Xu Y
    Platelets; 2000 Jun; 11(4):226-32. PubMed ID: 10938902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formation of [3H]inositol phosphates in human platelets by palmitoyl lysophosphatidic acid is blocked by indomethacin.
    Watson SP; Wolf M; Lapetina EG
    Biochem Biophys Res Commun; 1985 Oct; 132(2):555-62. PubMed ID: 3933504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
    Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
    Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux.
    Gerrard JM; Kindom SE; Peterson DA; Peller J; Krantz KE; White JG
    Am J Pathol; 1979 Aug; 96(2):423-38. PubMed ID: 112871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lysophosphatidic acids and their structural analogs on arterial blood pressure of cats.
    Tokumura A; Maruyama T; Fukuzawa K; Tsukatani H
    Arzneimittelforschung; 1985; 35(3):287-92. PubMed ID: 3846454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interaction of epinephrine and calcium ionophore in platelet aggregation.
    Butt IF; Saeed SA; Waqar SN; Aslam M
    J Ayub Med Coll Abbottabad; 2005; 17(2):1-5. PubMed ID: 16092638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor phosphatidate, but not platelet-activating factor, is a powerful calcium ionophore in the human red cell.
    Bussolino F; Camussi G; Arese P
    Cell Calcium; 1984 Oct; 5(5):463-73. PubMed ID: 6549153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mepacrine (quinacrine) inhibition of thrombin-induced platelet responses can be overcome by lysophosphatidic acid.
    McCrea JM; Robinson P; Gerrard JM
    Biochim Biophys Acta; 1985 Oct; 842(2-3):189-94. PubMed ID: 3931692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidic acid as a calcium ionophore in large unilamellar vesicle systems.
    Nayar R; Mayer LD; Hope MJ; Cullis PR
    Biochim Biophys Acta; 1984 Nov; 777(2):343-6. PubMed ID: 6435674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators?
    Simon MF; Chap H; Douste-Blazy L
    Biochem Biophys Res Commun; 1982 Oct; 108(4):1743-50. PubMed ID: 6924857
    [No Abstract]   [Full Text] [Related]  

  • 16. [The thrombocyte aggregating effect of phosphatidic acids and their lyso-derivatives (DAS)].
    Schumacher KA
    Fortschr Med; 1977 Dec; 95(45):2715-20. PubMed ID: 924337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epinephrine and the Ca2+ ionophore A23187 synergistically induce platelet aggregation without protein kinase C activation.
    Olbrich C; Siess W
    FEBS Lett; 1989 Jan; 243(2):275-9. PubMed ID: 2492953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zn(2+), derived from cell preparation, partly attenuates Ca(2+)-dependent cell death induced by A23187, calcium ionophore, in rat thymocytes.
    Sakanashi Y; Oyama TM; Matsuo Y; Oyama TB; Nishimura Y; Ishida S; Imai S; Okano Y; Oyama Y
    Toxicol In Vitro; 2009 Mar; 23(2):338-45. PubMed ID: 19124067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acids. II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog, rabbit, and human platelets.
    Gerrard JM; Kindom SE; Peterson DA; White JG
    Am J Pathol; 1979 Dec; 97(3):531-47. PubMed ID: 315721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidate and oxidized fatty acids are calcium ionophores. Studies employing arsenazo III in liposomes.
    Serhan C; Anderson P; Goodman E; Dunham P; Weissmann G
    J Biol Chem; 1981 Mar; 256(6):2736-41. PubMed ID: 6782095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.